Methyl Cinnamate

Methyl cinnamate is a naturally occurring ester of cinnamic acid found in essential oils of plants such as basil, cinnamon, and strawberries. It functions primarily as a fragrance and flavoring compound, with preclinical research suggesting interactions with olfactory receptors and weak antimicrobial activity, though no validated health benefits exist in human clinical trials.

Origin & History

Methyl cinnamate is a methyl ester of cinnamic acid, commonly appearing as white to slightly yellow crystals with a sweet aroma reminiscent of cherry or cinnamon. It is found naturally in essential oils like basil, galangal, and bay leaf, and is typically synthesized via the esterification of cinnamic acid with methanol.

Historical & Cultural Context

There is no documented historical or traditional medicinal use of methyl cinnamate. It is known primarily as a natural component in plant essential oils and as a flavoring agent.

Health Benefits

• No specific health benefits were identified in human clinical studies or RCTs. • The research dossier lacks evidence on methyl cinnamate’s health effects. • Its role is primarily as a flavoring agent due to its aromatic properties. • Further research is needed to establish any potential health benefits. • Current studies focus more on its chemical properties than biomedical applications.

How It Works

Methyl cinnamate is a phenylpropanoid ester formed from cinnamic acid and methanol, and preclinical data suggest it may weakly inhibit cyclooxygenase (COX-1 and COX-2) enzymes, potentially modulating prostaglandin synthesis in inflammatory pathways. In vitro studies indicate it may disrupt microbial cell membrane integrity by interfering with lipid bilayer organization, contributing to its observed antimicrobial activity against strains such as Staphylococcus aureus. Additionally, it activates olfactory receptor neurons via transient receptor potential (TRP) channels, which underlies its established role as an aromatic flavoring agent.

Scientific Research

There are no known human clinical trials, RCTs, or meta-analyses involving methyl cinnamate. Available research primarily discusses its chemical and flavor properties without PubMed PMIDs related to biomedical applications.

Clinical Summary

No randomized controlled trials (RCTs) or human clinical studies have specifically investigated the health effects of methyl cinnamate as an isolated compound. Available evidence is limited to in vitro cell studies and animal models, which cannot be directly extrapolated to human physiology or therapeutic dosing. One in vitro study demonstrated antifungal activity against Candida albicans at concentrations of 500–1000 µg/mL, but these concentrations have not been validated in vivo. The overall evidence base is insufficient to support any health claim, and methyl cinnamate remains classified as a flavoring and fragrance ingredient rather than a therapeutic supplement.

Nutritional Profile

Methyl cinnamate (C₆H₅CH=CHCOOCH₃; molecular weight 162.19 g/mol) is a methyl ester of cinnamic acid. It is not a nutritional substance and does not contribute macronutrients (protein, fat, carbohydrates) or micronutrients (vitamins, minerals) in any meaningful dietary quantity. • Primary classification: Aromatic ester / flavoring compound. • Bioactive identity: It is itself a single bioactive compound rather than a source of multiple nutrients. • Naturally occurring concentrations: Found in trace amounts in essential oils of certain plants, including Alpinia galanga (galangal), some basil (Ocimum) chemotypes (up to ~50–70% of essential oil content), and Syzygium aromaticum (clove). Typical dietary exposure through spice use is estimated in the low microgram-to-low-milligram range per serving. • Chemical properties: White crystalline solid; melting point ~34–36 °C; poorly water-soluble (log P ~2.6); soluble in ethanol and organic solvents. • Caloric contribution: Negligible at flavoring-level doses (FEMA GRAS status, typical use levels ~1–50 ppm in food products). • Bioavailability notes: Absorbed via the gastrointestinal tract; undergoes hydrolysis by esterases to yield cinnamic acid and methanol. Cinnamic acid is further metabolized via β-oxidation to benzoic acid, which is conjugated with glycine to form hippuric acid and excreted renally. Oral bioavailability of the parent ester is limited due to rapid first-pass hydrolysis. • Related bioactive metabolite: Cinnamic acid (the hydrolysis product) has been studied for antioxidant, anti-inflammatory, and antimicrobial properties, but these effects are attributed to the metabolite rather than methyl cinnamate itself. • No vitamins, minerals, fiber, or protein content. • No established Recommended Daily Intake or Adequate Intake values exist. • ADI (Acceptable Daily Intake): Not formally established by JECFA as a standalone value, but considered safe at current levels of use as a flavoring agent (FDA GRAS, FEMA No. 2698).

Preparation & Dosage

No clinically studied dosage ranges or forms are available, as no human studies have been conducted. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

basil oil, galangal extract, bay leaf oil

Safety & Interactions

Methyl cinnamate is Generally Recognized As Safe (GRAS) by the FDA when used as a flavoring agent at low concentrations typical in food applications. Topical application in cosmetics and fragrances has been associated with contact dermatitis and skin sensitization in susceptible individuals, and it is monitored by the International Fragrance Association (IFRA). No clinically documented drug-drug interactions have been established, though theoretical CYP450 enzyme interactions cannot be excluded given its structural similarity to other cinnamate derivatives. Safety data during pregnancy and lactation are absent, and supplemental use beyond food-level exposure is not recommended without further research.